Inhibiting Bone Morphogenetic Protein 4 Type I Receptor Signaling Promotes Remyelination by Potentiating Oligodendrocyte Differentiation

A. Cole(The University of Melbourne), Junhua Xiao(Swinburne University of Technology)

eNeuro

March 1, 2019

10.1523/eneuro.0399-18.2019

Cited by 25

Related Papers

A Brain-Derived Neurotrophic Factor-Based p75<sup>NTR</sup>Peptide Mimetic Ameliorates Experimental Autoimmune Neuritis Induced Axonal Pathology and Demyelination

|eNeuro|2017|33

Combined administration of SHP2 inhibitor SHP099 and the α7nAChR agonist PNU282987 protect mice against DSS‑induced colitis

|Molecular Medicine Reports|2020|19